B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE trials appear
Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo therapy could boost survival in adult leukemia patients
Disease control OngoingThis study tests whether adding the immunotherapy drug blinatumomab to standard chemotherapy helps adults with a certain type of acute lymphoblastic leukemia (ALL) live longer and stay cancer-free longer. About 488 adults with newly diagnosed BCR-ABL-negative B-ALL are participat…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:03 UTC
-
New combo therapy shows promise against hard-to-treat leukemia
Disease control OngoingThis study tests whether adding a targeted drug called tafasitamab to standard chemotherapy can improve outcomes for adults newly diagnosed with a fast-growing blood cancer (B-ALL) that lacks the Philadelphia chromosome. About 32 adults who are not good candidates for more intens…
Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA, PHILADELPHIA CHROMOSOME NEGATIVE
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 22, 2026 14:05 UTC